XBIOTECH INC. Total Liabilities and Equity
XBIOTECH INC. (XBIT) had Total Liabilities and Equity of $133.65 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $133.65M.
- 2026-03-31: Liabilities and Equity $139.84M.
- 2025-12-31: Liabilities and Equity $150.08M.
- 2025-09-30: Liabilities and Equity $172.42M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $133.65M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $139.84M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $150.08M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $172.42M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $178.68M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $181.86M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $199.09M 10-K · filed 2026-03-13 |
| 2024-09-30 | $209.85M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $215.56M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $227.86M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $226.62M 10-K · filed 2025-03-18 |
| 2023-09-30 | $229.60M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $235.14M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $242.12M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $246.10M 10-K · filed 2024-03-15 |
| 2022-09-30 | $250.83M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $266.46M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $270.80M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $275.18M 10-K · filed 2023-03-15 |
| 2021-09-30 | $279.52M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $353.96M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $355.94M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $353.74M 10-K · filed 2022-03-15 |
| 2020-09-30 | $353.39M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $358.76M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $358.37M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $816.88M 10-K · filed 2021-03-16 |
| 2019-09-30 | $66.64M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $71.88M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $39.82M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $44.34M 10-K · filed 2020-03-16 |
| 2018-09-30 | $49.24M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $54.29M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $58.86M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $62.97M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | $70.67M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $77.84M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $87.62M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $67.05M 10-K · filed 2018-03-16 |
| 2016-09-30 | $78.29M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $93.20M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $101.26M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $109.36M 10-K · filed 2017-03-16 |
| 2015-09-30 | $119.05M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $126.85M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $58.69M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $62.18M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |